Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?

BACKGROUND: There are insufficient data on continuous glucose monitoring (CGM) in nonintensive insulin therapy patients. Using CGM and the recommended CGM targets, we wanted to evaluate low-premix insulin analogue therapy (biphasic aspart/NovoMix 30 and biphasic lispro 25/Humalog Mix 25) in real-wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajnc, Mitja, Kravos Tramšek, Nika Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990036/
https://www.ncbi.nlm.nih.gov/pubmed/36882852
http://dx.doi.org/10.1186/s40001-023-01081-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990036/
https://www.ncbi.nlm.nih.gov/pubmed/36882852
http://dx.doi.org/10.1186/s40001-023-01081-y

Ejemplares similares